Company Filing History:
Years Active: 2015-2018
Title: The Innovative Contributions of Xianhua Cao
Introduction
Xianhua Cao is a notable inventor based in Hawthorn Woods, Illinois. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic proteins. With a total of three patents to his name, Cao's work focuses on addressing critical health challenges.
Latest Patents
Cao's latest patents include the "Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof." This patent discloses multivalent and multispecific binding proteins, along with methods for their production. These binding proteins have potential applications in the diagnosis, monitoring, inhibition, prevention, and treatment of cancers, tumors, and other angiogenesis-dependent diseases characterized by aberrant DLL4 and/or VEGF expression or activity.
Career Highlights
Cao is currently associated with AbbVie Inc., a leading global biopharmaceutical company. His work at AbbVie focuses on advancing therapeutic solutions that can significantly impact patient care and treatment outcomes.
Collaborations
Cao has collaborated with esteemed colleagues, including Jijie Gu and Dominic J Ambrosi. These collaborations have fostered a productive environment for innovation and research in the field of biotechnology.
Conclusion
Xianhua Cao's contributions to the field of biotechnology through his patents and collaborations highlight his commitment to advancing medical science. His innovative work continues to pave the way for new therapeutic approaches in the treatment of serious health conditions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.